Cargando…

P13-04. HIV positive women empowerment is equal to hiv prevalence reduction

Detalles Bibliográficos
Autores principales:	Akolo, MM, Kimani, J, Barassa, S, Lipesa, S, Gelmon, I
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767677/ http://dx.doi.org/10.1186/1742-4690-6-S3-P186

Ejemplares similares

Women HIV education, capacity building and economic empowerment initiative
por: Agochukwu, Caroline
Publicado: (2010)

P04-13. Complex pattern of neutralization of cell-to-cell HIV transmission to activated CD4+T cells
por: Massanella, M, et al.
Publicado: (2009)

P04.25. Complementary medicine use and potential adverse reactions amongst HIV-positive people
por: Braun, L, et al.
Publicado: (2012)

P04-15. Prevalence of broadly neutralizing antibody responses during acute/early HIV infection
por: Mikell, I, et al.
Publicado: (2009)

P04-50 LB. Prevalence of cross-reactive HIV-1 neutralizing activity in HIV-1 infected patients with rapid or slow disease progression
por: van Gils, MJ, et al.
Publicado: (2009)

P04-04. The specific phospholipid binding and neutralizing activities of the anti-HIV antibody 4E10 are separable
por: Xu, H, et al.
Publicado: (2009)

P04-46. Broadly cross-neutralizing activity in plasma of HIV-1 and HIV-2 infected individuals
por: Fenyö, E, et al.
Publicado: (2009)

Hepatitis B and hepatitis C prevalence in HIV positive pregnant women
por: Siame, Gilbert
Publicado: (2006)

P10-04. Mechanisms of HIV-1 detection by plasmacytoid dendritic cells
por: Lepelley, A, et al.
Publicado: (2009)

P04-20. Humoral immune response in acute HIV-1 infection
por: Mainetti, L, et al.
Publicado: (2009)

P04-08. Monoclonal antibodies from patient with acute HIV-1 infection
por: Chen, W, et al.
Publicado: (2009)

P04-52 LB. The importance of well-defined HIV-1 neutralization assays
por: Balla-Jhagjhoorsingh, SS, et al.
Publicado: (2009)

P04-53 LB. Potent and broad HIV-specific neutralizing antibodies in infants are not associated with prevention of mother to infant HIV transmission
por: Lynch, J, et al.
Publicado: (2009)

Prevalence of HBV infection in immunocompromised patients on ART nearly equals HBV mono infection in individuals not infected with HIV, Shimla Northern India
por: Garg, Aarti, et al.
Publicado: (2014)

P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection
por: Lederle, A, et al.
Publicado: (2009)

P04-33. Mechanisms of HIV-1 antibody mediated inhibition in Monomac-1 and MDM
por: Fischetti, L, et al.
Publicado: (2009)

P04-45. Characterization of the plasma cell repertoire in acute HIV-1 infection (AHI)
por: Liao, L, et al.
Publicado: (2009)

P07-04. HIV-1 evolution in mother to child transmission and pediatric disease progression
por: Dispinseri, S, et al.
Publicado: (2009)

P04-11. Prevalence of neutralizing antibody responses in chronic clades A and D human immunodeficiency virus type 1 (HIV-1) infections
por: Njai, HF, et al.
Publicado: (2009)

P01-04. Investigation of the sensitivity of acute-phase HIV-1 isolates to type I interferons
por: Dibben, O, et al.
Publicado: (2009)

P14-04. HIV-SELECTEST EIA and rapid test: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies
por: Khurana, S, et al.
Publicado: (2009)

P04-14. Sequential HIV-1 isolates from infected individuals reveals emergence of neutralization sensitive HIV-1 strains in the course of infection
por: Nyambi, PN, et al.
Publicado: (2009)

P04-13 How actively older persons age in Italy?
por: Contoli, Benedetta, et al.
Publicado: (2022)

P04-26. Immunological tolerance prevents the expression of a broadly reactive neutralizing HIV-1 antibody
por: Verkoczy, L, et al.
Publicado: (2009)

P04-37. Kinetic and thermodynamic factors determine HIV-1 neutralizing potency of MPER-specific antibodies
por: Ruprecht, C, et al.
Publicado: (2009)

P04-40. Dissecting pre- and post-attachment activity of HIV-1 entry inhibitors and neutralizing antibodies
por: Berlinger, L, et al.
Publicado: (2009)

P04-43. Neutralizing antibody responses against conformational envelope epitopes in early HIV-1 infection
por: Bar, KJ, et al.
Publicado: (2009)

P04-44. Generation of antibody responses to HIV-1 membrane proximal external region (MPER) antigen
por: Holl, TM, et al.
Publicado: (2009)

P04-49 LB. Adaptation of HIV-1 envelope glycoprotein to humoral immunity at a population level
por: Bunnik, EM, et al.
Publicado: (2009)

P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays
por: Brown, BK, et al.
Publicado: (2009)

P04-19. Analysis of the binding of multiple clades of HIV-1 by a modified virus capture assay
por: Peachman, K, et al.
Publicado: (2009)

Prevalence of ulcer forming STIs among HIV-positive women clinic attendees in two Nigerian hospitals
por: Awolade, Victoria, et al.
Publicado: (2012)

Pregnancy and contraception - the perspective of HIV-positive and negative women
por: Oraka, Chinedu O, et al.
Publicado: (2012)

P16-04. Cryptic CTL epitopes derived from antisense transcription are frequently recognized in HIV-1 infection
por: Bansal, A, et al.
Publicado: (2009)

P04-35. Neutralisation activity in a geographically diverse East London cohort of HIV-1 infected patients
por: Dreja, H, et al.
Publicado: (2009)

P04-36. HIV-1-speficic antibody dependant cellular cytotoxicity (ADCC) médiated by primary NK cells
por: Delaporte, M, et al.
Publicado: (2009)

P04-02. Increased breadth and potency of the neutralizing antibody response among dually-HIV-1-infected individuals
por: Powell, RL, et al.
Publicado: (2009)

Increased epithelial thickness and reduced HIV receptor expression in the ectocervical mucosa is associated with relative HIV resistance
por: Broliden, K, et al.
Publicado: (2012)

P19-04. A synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteins
por: Ilyichev, A, et al.
Publicado: (2009)

P04-06. Evolution of an anti-MPER gp41 antibody response that mediates broad HIV-1 cross-neutralization
por: Gray, E, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_m1gdsns3i0q10u9b8o49ghi8tt